{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:16:47Z","timestamp":1790691407263,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.nmd.2022.08.002","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T16:31:51Z","timestamp":1659803511000},"page":"806-810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Five patients with spinal muscular atrophy-progressive myoclonic epilepsy (SMA-PME): a novel pathogenic variant, treatment and review of the literature"],"prefix":"10.1016","volume":"32","author":[{"given":"Parvaneh","family":"Karimzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Najmabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Lochmuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5714-7500","authenticated-orcid":false,"given":"Marzieh","family":"Babaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima","family":"Dehdahsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Miryounesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Amirsalari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mansoor","family":"Rayegani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Hassan","family":"Tonekaboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2022.08.002_bib0001","series-title":"GeneReviews","first-page":"1","article-title":"Spinal muscular atrophy summary GeneReview scope","author":"Prior","year":"2020"},{"key":"10.1016\/j.nmd.2022.08.002_bib0002","series-title":"Child neurology","first-page":"1027","article-title":"Diseases of the motor unit","author":"Menkes","year":"2000"},{"key":"10.1016\/j.nmd.2022.08.002_bib0003","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review","volume":"12","author":"Verhaart","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2022.08.002_bib0004","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1684\/epd.2016.0858","article-title":"Spinal muscular atrophy associated with progressive myoclonus epilepsy","volume":"18","author":"Topaloglu","year":"2016","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.nmd.2022.08.002_bib0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13023-018-0845-z","article-title":"Acid ceramidase deficiency: farber disease and SMA-PME","volume":"13","author":"Yu","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2022.08.002_bib0006","doi-asserted-by":"crossref","first-page":"33110","DOI":"10.1074\/jbc.271.51.33110","article-title":"Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification Of the first molecular lesion causing Farber disease","volume":"271","author":"Koch","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2022.08.002_bib0007","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/epi.12977","article-title":"Spinal muscular atrophy associated with progressive myoclonic epilepsy: a rare condition caused by mutations in ASAH1","volume":"56","author":"Rubboli","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.nmd.2022.08.002_bib0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2012.05.001","article-title":"Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1","volume":"91","author":"Zhou","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2022.08.002_bib0009","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/humu.23880","article-title":"Iranome: a catalog of genomic variations in the Iranian population","volume":"40","author":"Fattahi","year":"2019","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2022.08.002_bib0010","first-page":"155","article-title":"A novel case report of spinal muscular atrophy with progressive myoclonic epilepsy from Iran","volume":"Volume 12","author":"Shervin Badv","year":"2019","journal-title":"Int Med Case Rep J"},{"key":"10.1016\/j.nmd.2022.08.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1068","article-title":"Polyarticular arthritis and spinal muscular atrophy in acid ceramidase deficiency","volume":"138","author":"Teoh","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2022.08.002_bib0012","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/ajmg.a.61764","article-title":"Spinal muscular atrophy and Farber disease due to ASAH1 variants: a case report","volume":"182","author":"Lee","year":"2020","journal-title":"Am J Med Genet Part A"},{"key":"10.1016\/j.nmd.2022.08.002_bib0013","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clineuro.2017.11.008","article-title":"Spinal muscular atrophy with progressive myoclonic epilepsy linked to mutations in ASAH1","volume":"164","author":"Yildiz","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.nmd.2022.08.002_bib0014","doi-asserted-by":"crossref","first-page":"424","DOI":"10.25122\/jml-2021-0147","article-title":"Clinical features and genetics in non-5q spinal muscular atrophy caused by acid ceramidase deficiency","volume":"14","author":"Axente","year":"2021","journal-title":"J Med Life"},{"key":"10.1016\/j.nmd.2022.08.002_bib0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-0040-1721543","article-title":"Spinal muscular atrophy and progressive myoclonic epilepsy: a rare association","volume":"12","author":"Radhakrishnan","year":"2021","journal-title":"J Neurosci Rural Pract"},{"key":"10.1016\/j.nmd.2022.08.002_bib0016","series-title":"GeneReviews\u24c7 [Internet].","article-title":"ASAH1-related disorders","author":"Dyment","year":"2018"},{"key":"10.1016\/j.nmd.2022.08.002_bib0017","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1038\/ejhg.2016.28","article-title":"ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: a clinical, biochemical and molecular study","volume":"24","author":"Filosto","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2022.08.002_bib0018","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/hum.2010.195","article-title":"Autologous transplantation of lentivector\/acid ceramidase-transduced hematopoietic cells in nonhuman primates","volume":"22","author":"Walia","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.nmd.2022.08.002_bib0019","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bmt.1702489","article-title":"Bone marrow transplantation for infantile ceramidase deficiency (Farber disease)","volume":"26","author":"Yeager","year":"2000","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.nmd.2022.08.002_bib0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41434-019-0085-4","article-title":"AAV9 vector: a novel modality in gene therapy for spinal muscular atrophy","volume":"26","author":"Pattali","year":"2019","journal-title":"Gene Ther"},{"key":"10.1016\/j.nmd.2022.08.002_bib0021","article-title":"Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine","volume":"2","author":"Chaytow","year":"2021","journal-title":"Cell Rep Med"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622006307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622006307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:12:27Z","timestamp":1760775147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896622006307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0960896622006307"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2022.08.002","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Five patients with spinal muscular atrophy-progressive myoclonic epilepsy (SMA-PME): a novel pathogenic variant, treatment and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2022.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}